Tretinoin 1 MG/ML Topical Cream — RxCUI 198300
RxNorm drug concept · Semantic clinical drug
RxCUI 198300
Semantic clinical drug · SCD
● Current RxNorm concept 33 FDA products
57 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI198300
Official nameTretinoin 1 MG/ML Topical Cream
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known astretinoin 0.1 % Topical Cream
FDA products mapped33
Package NDCs mapped57
Reported Medicaid activity (SDUD)952,243 prescriptions · 49 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Tretinoin: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Honestly, it won't erase wrinkles — and the label is pretty direct about that. What it's approved to do is help reduce the appearance of fine wrinkles as part of a full routine tha...
- Will tretinoin actually get rid of my wrinkles?
- Redness, peeling, and irritation in the first couple of weeks are very common and usually mean your skin is adjusting — not that something is wrong. If it's tolerable, try hanging...
- My skin is really red and peeling after the first week — should I stop?
🕸️ Concept Web — How Tretinoin 1 MG/ML Topical Cream Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Tretinoin 1 MG/ML Topical Cream
RxCUI 198300 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Tretinoin
10753IN
-
Tretinoin
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Retin-A
153101BN
-
Retin-A
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Tretinoin Topical Cream
377828SCDF -
Tretinoin Topical Product
1158220SCDG -
Tretinoin Topical Cream [Retin-A]
362106SBDF -
Retin-A Topical Product
1182535SBDG -
Topical Cream
316982DF -
Topical Product
1151122DFG
-
Tretinoin Topical Cream
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Tretinoin 1 MG/ML
335768SCDC -
Tretinoin 1 MG/ML Topical Cream [Retin-A]
208331SBD -
Tretinoin 1 MG/ML [Retin-A]
569036SBDC
-
Tretinoin 1 MG/ML
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Tretinoin 1 MG/ML
SCDC · 335768 -
Tretinoin Topical Cream
SCDF · 377828 -
Tretinoin Topical Product
SCDG · 1158220
Brand-Name Concepts
-
Tretinoin 1 MG/ML Topical Cream [Retin-A]
SBD · 208331 -
Tretinoin 1 MG/ML [Retin-A]
SBDC · 569036 -
Tretinoin Topical Cream [Retin-A]
SBDF · 362106 -
Retin-A Topical Product
SBDG · 1182535 -
Retin-A
BN · 153101
📦 FDA Products & Package NDCs
33 products · 57 package NDCs
57 package NDCs map to RxCUI 198300 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 68071-3826-02 | 1 TUBE in 1 CARTON (68071-3826-2) / 20 g in 1 TUBE | Tretinoin | NuCare Pharmaceuticals, Inc. | 2025-04-02 |
| 68071-3889-02 | 1 TUBE in 1 CARTON (68071-3889-2) / 20 g in 1 TUBE | Tretinoin | NuCare Pharmaceuticals,Inc. | 2025-09-03 |
| 70518-3233-00 | 1 TUBE in 1 CARTON (70518-3233-0) / 20 g in 1 TUBE | TRETINOIN | REMEDYREPACK INC. | 2021-10-11 |
| 70771-1873-02 | 1 TUBE in 1 CARTON (70771-1873-2) / 20 g in 1 TUBE | Tretinoin | Zydus Lifesciences Limited | 2024-04-30 |
| 70771-1873-04 | 1 TUBE in 1 CARTON (70771-1873-4) / 45 g in 1 TUBE | Tretinoin | Zydus Lifesciences Limited | 2024-04-30 |
| 72578-0153-08 | 1 TUBE in 1 CARTON (72578-153-08) / 45 g in 1 TUBE | Tretinoin | Viona Pharmaceuticals Inc | 2024-04-30 |
| 72578-0153-09 | 1 TUBE in 1 CARTON (72578-153-09) / 20 g in 1 TUBE | Tretinoin | Viona Pharmaceuticals Inc | 2024-04-30 |
Observed labelers:
Bausch Health US, LLC (10) ·
Mylan Pharmaceuticals Inc. (10) ·
Padagis US LLC (10) ·
Encube Ethicals, Inc. (6) ·
A-S Medication Solutions (3) ·
Obagi Cosmeceuticals LLC (3)
· +9 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.